Atacand Label May Note 2 mm Hg BP Reduction Over Cozaar, Cmte. Says
Executive Summary
AstraZeneca's Atacand labeling may claim a 2 mm Hg reduction in diastolic blood pressure over Merck's Cozaar, FDA's Cardiovascular and Renal Drugs Advisory Committee said July 18